Veru Inc.
- Last sale
- Nov 12, 2026 · +0.24%
- Market cap
- $36.15M
- 17.05M shares
- Filings
- 1,006
Q3 2025+3.6% FY24 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q2 2024N/M FY23 yoy
Q3 2026−36.6% FY25 yoy
- $36.15M
- —
- —
- 1.3×
- -83.12%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2024 | 2024-09-30 | $16,886,419 | reported | |
| FY 2023 | 2023-09-30 | $16,296,958 | reported | |
| FY 2022 | 2022-09-30 | $39,354,352 | reported | |
| FY 2021 | 2021-09-30 | $61,259,528 | reported | |
| FY 2020 | 2020-09-30 | $42,592,060 | reported | |
| FY 2019 | 2019-09-30 | $31,803,387 | reported | |
| FY 2018 | 2018-09-30 | $15,864,483 | reported | |
| FY 2017 | 2017-09-30 | $13,655,592 | reported | |
| FY 2016 | 2016-09-30 | $22,127,342 | reported | |
| FY 2015 | 2015-09-30 | $32,604,865 | reported | |
| FY 2014 | 2014-09-30 | $24,491,000 | reported | |
| FY 2013 | 2013-09-30 | $31,457,000 revised | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2015 | $5.34K | $950.00 | $6.29K | — | 29.02M sh | +0.7% | — |
| FY2014 | $6.10M | $737.75K | $6.84M | $0.21 | 28.82M sh | +0.3% | 191.6% |
| FY2013 | $7.50M | $395.67K | $7.90M | $0.26 | 28.73M sh | +0.2% | 68.7% |
| FY2012 | $6.20M | $289.61K | $6.49M | $0.22 | 28.67M sh | +2.9% | 67.3% |
| FY2011 | $5.50M | $33.06K | $5.53M | $0.20 | 27.88M sh | +1.5% | 79.9% |
Segments
LineFY2021ShareChange
FC2 Segment$60.40M99%+48.9%
PREBOOST Segment$862.83K1.4%−57.6%
Total$61.26M
Pharmaceutical preparations
Veru Inc. is the 350th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
GRCEGrace Therapeutics, Inc.———$38.0MATHEAlterity Therapeutics Ltd———$37.9MALDXAldeyra Therapeutics, Inc.———$37.7MSERSerina Therapeutics, Inc.$130.0K132.1%14,755.4%$37.7MAPLMApollomics Inc.Fiscal 2024 figures———$37.6M
VERUVeru Inc. (this company)———$36.1M
TELOTelomir Pharmaceuticals, Inc.———$36.1MANVSAnnovis Bio, Inc.$0.0——$35.7MOSTXOS Therapies Inc———$35.3MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Veru Inc. · CIK 863894 · Engraved from SEC EDGAR